The Infamous Wuhan Lab Recently Assembled Monkeypox Strains Using Methods Flagged For Creating ‘Contagious Pathogens’.

The Wuhan Institute of Virology assembled a monkeypox virus genome, allowing the virus to be identified through PCR tests, using a method researchers flagged for potentially creating a “contagious pathogen,” The National Pulse can reveal.

The study was first published in February 2022, just months before the latest international outbreak of monkeypox cases which appear to have now reached the United States.

The paper, which was authored by nine Wuhan Institute of Virology researchers and published in the lab’s quarterly scientific journal Virologica Sinica, also follows the wide-scale use of Polymerase Chain Reaction (PCR) tests to identify COVID-19-positive individuals.

Researchers appeared to identify a portion of the monkeypox virus genome, enabling PCR tests to identify the virus, in the paper: “Efficient Assembly of a Large Fragment of Monkeypox Virus Genome as a qPCR Template Using Dual-Selection Based Transformation-Associated Recombination.”

Keep reading

Monkeypox Was a Table-Top Simulation Only Last Year

Elite media outlets around the world are on red alert over the world’s first-ever global outbreak of Monkeypox in mid-May 2022—just one year after an international biosecurity conference in Munich held a simulation of a “global pandemic involving an unusual strain of Monkeypox” beginning in mid-May 2022.

Monkeypox was first identified in 1958, but there’s never been a global Monkeypox outbreak outside of Africa until now—in the exact week of the exact month predicted by the biosecurity folks in their pandemic simulation. Take these guys to Vegas!

Keep reading

WHO Warns Summer Festivals, Mass Gatherings Could Accelerate Spread of Monkeypox

The WHO is warning that summer festivals and mass gatherings could accelerate the spread of monkeypox in the first indication that health technocrats may once again attempt to impose restrictions in the name of stopping the spread of a virus.

Monkeypox cases in the UK, where the virus first arrived thanks to someone traveling back from Nigeria, have more than doubled, it was revealed earlier today.

At least nine other countries around the world have also reported suspected cases of the virus, which can cause severe illness in young children, pregnant women, and individuals who are immunocompromised.

Clusters of cases have been observed amongst homosexual men, who are more at risk of catching the virus from sexual partners.

According to Sky News, “Exactly what is driving the UK’s largest outbreak is a mystery,” especially as health experts previously asserted that monkeypox wasn’t very transmissible amongst humans, with some speculating it has mutated.

Now the World Health Organization is warning that summer festivals and mass gatherings could accelerate the spread of monkeypox.

“As we enter the summer season in the European region, with mass gatherings, festivals and parties, I am concerned that transmission could accelerate, as the cases currently being detected are among those engaging in sexual activity, and the symptoms are unfamiliar to many,” said Dr Hans Kluge, WHO regional director for Europe.

The virus is also spreading at the same time the WHO is preparing to vote on an international pandemic treaty and amendments to the International Health Regulations (2005).

According to critics, the treaty would, “give the unelected WHO greater control of national emergency healthcare decisions and new powers to push vaccine passports, global surveillance, and “global coordinated actions” that address “misinformation” whenever it declares a “health emergency.”

Of course, all those fears will naturally be dismissed as “misinformation” by WHO-aligned ‘fact checkers’ in due course.

Keep reading

Biden Admin Places $119 Million Order for Vaccines After Single Case of Monkeypox Reported in US

The Biden administration has placed an order for millions of doses of a vaccine intended to protect against smallpox and monkeypox, after the first case of monkeypox in the United States this year was confirmed in Massachusetts on May 18.

Monkeypox, a viral disease typically limited to Africa, has been reported in several countries with more than 25 confirmed cases since the beginning of May.

Denmark-based biotech group Bavarian Nordic announced the order on May 18, which prompts the company to convert its bulk liquid smallpox vaccine into freeze-dried versions, which have an improved shelf life. The bulk vaccine has already been manufactured and invoiced under previous contracts with the U.S. government, the Bavarian Nordic stated. The vaccine is approved under the name “JYNNEOS” in the United States.

The order represents $119 million worth of the Jynneos vaccines, which would be manufactured and invoiced in 2023 and 2024.

Under the contract, the Biden administration has the option to place another order worth $180 million. That would allow for about 13 million freeze-dried doses of the Jynneos smallpox vaccine to be manufactured by around 2024 and 2025. The majority of the bulk vaccine for those doses has already been manufactured and invoiced, according to the company.

Keep reading